• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
60 Degrees Pharmaceuticals, Inc. - Common Stock
Adamas One Corp. - Common Stock
American Superconductor Corporation - Common Stock
Biofrontera Inc. - Common Stock
Pinterest, Inc. Class A Common Stock
Propanc Biopharma, Inc. - Common Stock
Semtech Corporation - Common Stock
Smart Powerr Corp. - Common Stock
Strata Skin Sciences, Inc. - Common Stock
Themes Cybersecurity ETF
Vacasa, Inc. - Class A Common Stock
Visteon Corporation - Common Stock
Vital Farms, Inc. - Common Stock
Vivos Therapeutics, Inc. - Common Stock
Wesdome Gold Mines Ltd
Edit Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Dermata Therapeutics, Inc. - Common Stock (NQ:DRMA)

0.9111 +0.0011 (+0.12%)
Delayed Quote Updated: 2:49 PM EDT, Oct 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,264,377
Open 0.9090
Bid (Size) 0.9021 (500)
Ask (Size) 0.9202 (1,300)
Prev. Close 0.9100
Today's Range 0.8100 - 0.9504
52wk Range 0.6032 - 4.660
Shares Outstanding 1,026,457
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Stocks to Watch: WETO, PRSO, DRMA, SNES Highlight Robotics, Defense, Skincare and Revenue Growth
October 15, 2026
Via AB Newswire
Topics Artificial Intelligence
News headline image
Graphene Manufacturing (OTCQX: GMGMF) Reports Battery Energy Density Gains
October 15, 2026
Via AB Newswire
Topics Artificial Intelligence

Performance

52-Week Range 80.4% below 52-week high
0.9111
0.6052W Low 4.6652W High
1 Week 22.8% below 1-week high
0.601W Low 1.181W High

Dermata Therapeutics, Inc. - Common Stock (DRMA) traded between $0.60 and $4.66 over the past 52 weeks and last traded at $0.91, 80.4% below its 52-week high. Over the past week it ranged between $0.60 and $1.18.

Past 12 Months
-10.7%
-19.4%
-28.8%
-32.5%
-58.2%
-78.9%
1W -$0.11
1M -$0.22
3M -$0.37
6M -$0.44
YTD -$1.27
1Y -$3.41

DRMA was -78.9% over the past year, -32.5% over six months, -58.2% year to date, -10.7% in the last week.

12 Months vs Market
DRMA
-78.9%
DIA
+12.0%
SPY
+14.6%
QQQ
+17.9%
IWM
+8.0%

Over the past 12 months DRMA returned -78.9% versus DIA (Dow) +12.0%, SPY (S&P 500) +14.6%, QQQ (Nasdaq 100) +17.9% and IWM (Russell 2000) +8.0%.

Volume & Liquidity 0.68× 3-mo avg
Today 2,264,377 3-mo avg 3.3M
1W
34.1M
1M
7.4M
3M
3.3M
6M
1.7M
YTD
1.8M
1Y
1.6M

DRMA most recently traded 2,264,377 shares against a 3-month average daily volume of 3.3M.

More News

Read More
Which stocks are most active on Thursday? ↗
October 15, 2026
Via Chartmill
Top stock movements in today's session. ↗
October 15, 2026
Via Chartmill
Dermata Therapeutics (NASDAQ:DRMA) Q1 2026 Earnings: Narrowing Losses and Strategic Pivot to DTC Skincare ↗
May 13, 2026
Via Chartmill
Get insights into the top gainers and losers of Thursday's pre-market session. ↗
October 15, 2026
Via Chartmill
News headline image
Dermata Therapeutics Announces Positive Topline Results from Cosmetic Study Evaluating Its Tome Foundational Treatment
October 15, 2026
From Dermata Therapeutics
Via ACCESS Newswire
News headline image
Dermata Therapeutics Announces Commercial Launch of Tome Foundational Treatment
August 25, 2026
From Dermata Therapeutics
Via ACCESS Newswire
News headline image
Dermata Announces Preorders Now Open for Tome Foundational Treatment Ahead of Commercial Launch
August 21, 2026
From Dermata Therapeutics
Via ACCESS Newswire
News headline image
Dermata Therapeutics Announces $3.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
August 17, 2026
From Dermata Therapeutics
Via ACCESS Newswire
Unusual volume stocks are being observed in Wednesday's session. ↗
August 12, 2026
Via Chartmill
The market is filled with gapping stocks in Wednesday's session. ↗
August 12, 2026
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
August 11, 2026
Via Benzinga
News headline image
Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Second Quarter 2026
August 11, 2026
From Dermata Therapeutics
Via ACCESS Newswire
News headline image
Dermata Therapeutics Announces Commercial Launch Date for Tome(TM) Foundational Treatment
August 05, 2026
From Dermata Therapeutics
Via ACCESS Newswire
News headline image
Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the First Quarter 2026
May 13, 2026
Via ACCESS Newswire
News headline image
Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Application of Dermal Fillers with its Bioneedle Delivery System
April 02, 2026
Via ACCESS Newswire
News headline image
Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Year Ended 2025
March 26, 2026
Via ACCESS Newswire
What's going on in today's session ↗
March 20, 2026
Via Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
March 20, 2026
Via Chartmill
Stay updated with the stocks that are on the move in today's pre-market session. ↗
March 20, 2026
Via Chartmill
Get insights into the top gainers and losers of Thursday's after-hours session. ↗
March 19, 2026
Via Chartmill
News headline image
Dermata Announces Appointment of Kyra Peckaitis as Vice President, Marketing
March 10, 2026
Via ACCESS Newswire
News headline image
Dermata Opens a New Chapter with the Release of Tome Skincare
March 05, 2026
Via ACCESS Newswire
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
February 20, 2026
Via Chartmill

Frequently Asked Questions

Is Dermata Therapeutics, Inc. - Common Stock publicly traded?
Yes, Dermata Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Dermata Therapeutics, Inc. - Common Stock trade on?
Dermata Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Dermata Therapeutics, Inc. - Common Stock?
The ticker symbol for Dermata Therapeutics, Inc. - Common Stock is DRMA on the Nasdaq Stock Market
What is the current price of Dermata Therapeutics, Inc. - Common Stock?
The current price of Dermata Therapeutics, Inc. - Common Stock is 0.9111
When was Dermata Therapeutics, Inc. - Common Stock last traded?
The last trade of Dermata Therapeutics, Inc. - Common Stock was at 10/16/26 02:49 PM ET
What is the market capitalization of Dermata Therapeutics, Inc. - Common Stock?
The market capitalization of Dermata Therapeutics, Inc. - Common Stock is 935.20K
How many shares of Dermata Therapeutics, Inc. - Common Stock are outstanding?
Dermata Therapeutics, Inc. - Common Stock has 935K shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap